Early stopping of randomized clinical trials for overt efficacy is problematic

Dirk Bassler, Victor M. Montori, Matthias Briel, Paul Glasziou, Gordon Guyatt*

*Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

96 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Early stopping of randomized clinical trials for overt efficacy is problematic'. Together they form a unique fingerprint.

Medicine & Life Sciences